Findings from a randomized controlled trial (RCT) in Botswana revealed that ART-naïve HIV patients receiving 24 months of micronutrient supplementation had a significantly lower risk of reaching CD4 T lymphocyte counts ≤250 cells/μL, and experiencing AIDS-related conditions or death, when compared to a placebo group [11]. The gene discussed is CD4; the disease is AIDS.